Novo Nordisk detailed the progress they have made in implementing their remediation plan at the Bloomington facility and affirmed that they expect the facility to be ready for reinspection by the end ...
AI-generated summary reviewed by our newsroom. Read our AI Policy. North Carolina clinics first noted weight loss from GLP‑1 diabetes drugs in 2016. GLP‑1 medicines suppress appetite and triggered a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback